Calculated low density lipoprotein cholesterol levels frequently underestimate directly measured low density lipoprotein cholesterol determinations in patients with serum triglyceride levels ≤ 4.52 mmol/l:: An analysis comparing the LipiDirect® magnetic LDL assay with the Friedewald calculation

被引:31
作者
Tighe, DA
Ockene, IS
Reed, G
Nicolosi, R
机构
[1] Univ Massachusetts, Sch Med, Dept Med, Div Cardiovasc Med, Worcester, MA 01655 USA
[2] Univ Massachusetts, Sch Med, Worcester, MA 01655 USA
[3] Univ Massachusetts, Dept Clin Sci, Lowell, MA 01854 USA
关键词
cholesterol; low density lipoprotein; Friedewald formula; direct LDL-C assays; triglycerides;
D O I
10.1016/j.cca.2005.08.026
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
Background: Increased low density lipoprotein cholesterol (LDL-C) is an established risk factor for the development of coronary artery disease (CAD). Recent guidelines detail specific LDL-C cutpoints for therapeutic goals. In practice, LDL-C is usually derived from the Friedewald formula (FF). This calculation is known to be inaccurate with serum triglyceride (TG) concentrations > 4.52 mmol/l, however, its accuracy among relatively healthy patient cohorts with TG concentrations <= 4.52 mmol/l is less well studied. Methods: We studied 661 ambulatory adults with TG concentrations <= 4.52 mmol/l and no overt CAD. Fasting venous lipid panels were obtained. LDL-C was calculated from the FF and also directly measured with the LipiDirect (R) Magnetic LDL assay. Linear regression and paired t-test analyses were performed. Results: Calculated and directly measured LDL-C concentrations were significantly different (4.26 +/- 0.88 vs. 4.83 +/- 1.06 mmol/l respectively, p < 0.0001). In 93% of measurements directly measured LDL-C exceeded calculated LDL-C. Although calculated and directly measured LDL-C concentrations were related (R=0.90), the discrepancy between them increased linearly with increasing TG concentrations (R=0.67) and clinically important differences existed at normal or slightly increased TG concentrations. Concordant results for NCEP ATP-III risk categories. were present for only 48.1% of samples. Conclusions: Significant differences between calculated and directly measured LDL-C using the LipiDirect (R) Magnetic LDL assay exist in healthy subjects with TG <= 4.52 mmol/l. These differences are linearly related to TG concentrations and occur frequently at relatively low TG concentrations. (c) 2005 Elsevier B.V. All rights reserved.
引用
收藏
页码:236 / 242
页数:7
相关论文
共 35 条
[21]  
RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P365
[22]  
RIFKIND BM, 1984, JAMA-J AM MED ASSOC, V251, P351
[23]   CALCULATED LOW-DENSITY-LIPOPROTEIN CHOLESTEROL SHOULD NOT BE USED FOR MANAGEMENT OF LIPOPROTEIN ABNORMALITIES IN PATIENTS WITH DIABETES-MELLITUS [J].
RUBIESPRAT, J ;
REVERTER, JL ;
SENTI, M ;
PEDROBOTET, J ;
SALINAS, I ;
LUCAS, A ;
NOGUES, X ;
SANMARTI, A .
DIABETES CARE, 1993, 16 (08) :1081-1086
[24]   The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels [J].
Sacks, FM ;
Pfeffer, MA ;
Moye, LA ;
Rouleau, JL ;
Rutherford, JD ;
Cole, TG ;
Brown, L ;
Warnica, JW ;
Arnold, JMO ;
Wun, CC ;
Davis, BR ;
Braunwald, E .
NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) :1001-1009
[25]  
Scandinavian Simvastatin Survival Group, 1994, LANCET, V89, P1329
[26]   Secondary prevention of coronary heart disease in patients with extracoronary atherosclerosis: A need for accuracy of low density lipoprotein determination [J].
Senti, M ;
PedroBotet, J ;
RubiesPrat, J ;
VidalBarraquer, F .
ANGIOLOGY, 1996, 47 (03) :241-246
[27]   PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA [J].
SHEPHERD, J ;
COBBE, SM ;
FORD, I ;
ISLES, CG ;
LORIMER, AR ;
MACFARLANE, PW ;
MCKILLOP, JH ;
PACKARD, CJ .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) :1301-1307
[28]  
Sniderman AD, 1997, CLIN CHEM, V43, P1310
[29]   RELATIONSHIP OF BASE-LINE MAJOR RISK-FACTORS TO CORONARY AND ALL-CAUSE MORTALITY, AND TO LONGEVITY - FINDINGS FROM LONG-TERM FOLLOW-UP OF CHICAGO COHORTS [J].
STAMLER, J ;
DYER, AR ;
SHEKELLE, RB ;
NEATON, J ;
STAMLER, R .
CARDIOLOGY, 1993, 82 (2-3) :191-222
[30]   IS RELATIONSHIP BETWEEN SERUM-CHOLESTEROL AND RISK OF PREMATURE DEATH FROM CORONARY HEART-DISEASE CONTINUOUS AND GRADED - FINDINGS IN 356 222 PRIMARY SCREENEES OF THE MULTIPLE RISK FACTOR INTERVENTION TRIAL (MRFIT) [J].
STAMLER, J ;
WENTWORTH, D ;
NEATON, JD .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1986, 256 (20) :2823-2828